Composition and method for producing stable amyloid beta oligomers of high molecular weight

Details for Australian Patent Application No. 2006266213 (hide)

Owner Merck & Co., Inc.

Inventors Nawrocki, Denise; Thiriot, David; Evans, Robert; Mach, Henryk

Agent Spruson & Ferguson

Pub. Number AU-A-2006266213

PCT Pub. Number WO2007/005359

Priority 60/695,526 30.06.05 US

Filing date 26 June 2006

Wipo publication date 11 January 2007

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/005359 Priority application(s): WO2007/005359

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006266227-Application security in an interactive media environment

2006266212-Method for preparing a covalently cross linked oligomer of amyloid beta peptides